PHARMACEUTICAL MEDICINAL FORMS CONTAINING TASK-1 AND TASK-3 CHANNEL INHIBITORS AND THEIR APPLICATION FOR TREATMENT OF RESPIRATORY DISORDERS

摘要

The present invention relates to new pharmaceutical dosage forms containing potent and selective inhibitors of the TASK-1 and / or TASK-3 channels, and their use for the treatment and / or prevention of respiratory disorders, including respiratory disorders in sleep, such as obstructive and central sleep apnea and snore.